DRIO - DarioHealth Corp.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.95
0.00 (0.00%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close0.95
Open0.95
Bid0.90 x 1400
Ask1.45 x 800
Day's Range0.92 - 0.95
52 Week Range0.85 - 3.64
Volume38,271
Avg. Volume47,293
Market Cap24.328M
Beta (3Y Monthly)0.38
PE Ratio (TTM)N/A
EPS (TTM)-1.10
Earnings DateNov 12, 2018 - Nov 16, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.50
Trade prices are not sourced from all markets
  • DarioHealth to Host Investor Conference Call on October 4, 2018
    PR Newswire27 days ago

    DarioHealth to Host Investor Conference Call on October 4, 2018

    Call to review recent fundraise, expected accelerated growth, and introduce new President and new Chairman CAESAREA, Israel , Sept. 20, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading ...

  • DarioHealth Closes on $10,345,000 Through Private Placement Offering
    PR Newswirelast month

    DarioHealth Closes on $10,345,000 Through Private Placement Offering

    CAESAREA, Israel, Sept. 14, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that it has closed on a private placement offering with institutional and private investors for the sale of shares of the Company's common stock and shares of the Company's newly designated Series D convertible preferred stock.

  • DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer
    PR Newswirelast month

    DarioHealth Appoints Olivier Jarry, Former Head of Diabetes Care at Bayer and Executive at Novartis and Bristol-Myers-Squibb, as President and Chief Commercial Officer

    CAESAREA, Israel, Sept. 5, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Olivier Jarry, a prominent global life sciences and consumer health executive, has joined the Company as President and Chief Commercial Officer. Mr. Jarry brings to DarioHealth more than 30 years of experience improving health and living standards throughout Western and Eastern Europe, the Americas and Asia.

  • DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management
    PR Newswire2 months ago

    DarioHealth Chosen by Attain Health for Pilot Study to Improve Cystic Fibrosis Related Diabetes Management

    CAESAREA, Israel, Aug. 22, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has entered into an agreement with Attain Health, a provider of integrative health coaching for individuals living with cystic fibrosis, to pilot the DarioEngage platform for the management of cystic fibrosis related diabetes (CFRD). CFRD is a unique from of diabetes that occurs in a subset of the estimated 30,000 Americans and 70,000 people worldwide living with cystic fibrosis.

  • DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore
    PR Newswire2 months ago

    DarioHealth to Exhibit at American Association of Diabetes Educators Conference on August 17-20 in Baltimore

    CAESAREA, Israel, Aug. 15, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it will exhibit the DarioEngage platform and its other digital health products at the American Association of Diabetes Educators (AADE) annual conference at booth #348 on August 17-20, 2018 in Baltimore, Maryland. The AADE is a professional membership organization dedicated to improving diabetes care through innovative education, management, and support with more than 14,000 members including nurses, dietitians, pharmacists, and exercise specialists.

  • DarioHealth Reports Second Quarter 2018 Results
    PR Newswire2 months ago

    DarioHealth Reports Second Quarter 2018 Results

    - Record Q2 2018 revenue of $2.06 million marks 70% growth year over year - Sequential quarterly growth of 17% - Cash burn reduced by 27% from previous quarter NEW YORK and CAESAREA, Israel , Aug. 9, 2018 ...

  • ACCESSWIRE2 months ago

    DarioHealth Corp. to Host Earnings Call

    NEW YORK, NY / ACCESSWIRE / August 9, 2018 / DarioHealth Corp. (NASDAQ: DRIO ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 9, 2018 at 9:00 AM Eastern Time. ...

  • DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018
    PR Newswire3 months ago

    DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018

    Earnings and Business Update Conference Call Scheduled for 9:00am EDT NEW YORK and CAESAREA, Israel , Aug. 1, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ...

  • DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018
    PR Newswire3 months ago

    DarioHealth to Host Second Quarter 2018 Conference Call on August 9, 2018

    Earnings and Business Update Conference Call Scheduled for 9:00am EDT NEW YORK and CAESAREA, Israel , July 31, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ...

  • DarioHealth Launches New Annual Membership & Product Enhancements to Promote Long-Term Use, Higher Levels of User Engagement, and Associated Sustainable Behavioral Changes
    PR Newswire3 months ago

    DarioHealth Launches New Annual Membership & Product Enhancements to Promote Long-Term Use, Higher Levels of User Engagement, and Associated Sustainable Behavioral Changes

    CAESAREA, Israel, July 25, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that following new data presented at the American Diabetes Association (ADA) on June 25, 2018 showing long-term sustainable clinical results, the Company has launched new product offerings and enhancements to promote the long-term use of its digital health platform. DarioHealth recently announced very compelling data from over 17,000 people who used its integrated digital health solution in 2017.

  • DarioHealth CEO Erez Raphael's Interview Published in Research 2 Guidance
    PR Newswire3 months ago

    DarioHealth CEO Erez Raphael's Interview Published in Research 2 Guidance

    CAESAREA, Israel, July 12, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today that Research2Guidance, an analyst and strategic consulting company for the digital health industry, published an interview of DarioHealth CEO, Erez Raphael titled "Using real-time data to feed predictive care models for diabetes management." The interview covers topics including DarioHealth's position and strategy in the digital health market, as well as industry trends and a look at how users integrate digital health technologies into their daily lives to create measurable health benefits.

  • DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board
    PR Newswire3 months ago

    DarioHealth Appoints Healthcare Technology Entrepreneur and Venture Capital Partner Yoav Shaked as Chairman of the Board

    CAESAREA, Israel, July 9, 2018 /PRNewswire/ --– DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, announced today Yoav Shaked has joined the Company as Chairman of the Board. Mr. Shaked is a partner at Sequoia Capital, a world leading venture capital firm.

  • PR Newswire4 months ago

    DarioHealth Presents New Data at American Diabetes Association's 78th Scientific Sessions on June 25, 2018

    CAESAREA, Israel, June 25, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today reported new data at the American Diabetes Association's (ADA) 78th Scientific Sessions which takes place in Orlando, Florida from June 22-26, 2018. On Monday June 25, 2018 from 12:00 pm – 1:00pm ET, DarioHealth's Head of Commercialization for North America, JC Muyl, is delivering three poster presentations.

  • DarioHealth to Deliver Three Poster Presentations With New Data at American Diabetes Association on June 25, 2018
    PR Newswire4 months ago

    DarioHealth to Deliver Three Poster Presentations With New Data at American Diabetes Association on June 25, 2018

    NEW YORK and CAESAREA, Israel , June 21, 2018 DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile health and big data solutions, today announced JC Muyl, the Company's ...

  • DarioHealth Set to Join Russell Microcap® Index Effective June 25, 2018
    PR Newswire4 months ago

    DarioHealth Set to Join Russell Microcap® Index Effective June 25, 2018

    NEW YORK and CAESAREA, Israel, June 19, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today that its stock will be added to the Russell Microcap® Index, effective at market open on Monday, June 25, 2018. Membership in the Russell Microcap® Index, which remains in place for one year, means automatic inclusion in the appropriate growth and value style indexes. FTSE Russell determines membership for its Russell US Indexes primarily by objective, market-capitalization rankings and style attributes.

  • DarioHealth Provides Update on Recently Launched iPhone 7, 8 and X Smart Glucose Meter in the U.S. Following FDA Clearance
    PR Newswire4 months ago

    DarioHealth Provides Update on Recently Launched iPhone 7, 8 and X Smart Glucose Meter in the U.S. Following FDA Clearance

    DarioHealth Reveals First Indication of U.S. Market Opportunity NEW YORK and CAESAREA, Israel , June 7, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with ...

  • PR Newswire5 months ago

    DarioHealth to Present at Chardan's Digital Health Conference

    Presentation to be Given by Erez Raphael, Chairman and CEO of DarioHealth SAN FRANCISCO , May 21, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company with mobile ...

  • DarioHealth Reports First Quarter 2018 Results
    PR Newswire5 months ago

    DarioHealth Reports First Quarter 2018 Results

    Record Q1 2018 Revenue of $1.76 Million ; year over year growth of 74% NEW YORK and CAESAREA, Israel , May 15, 2018 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ...

  • DarioHealth Releases Next Generation Version 4.0 of its Award-Winning App
    PR Newswire5 months ago

    DarioHealth Releases Next Generation Version 4.0 of its Award-Winning App

    NEW YORK and CAESAREA, Israel, May 8, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced the availability of its award-winning next-generation app, version 4.0. The upgraded user-centric Dario app now includes a two-way coaching chat platform that aims to improve user experience and the way diabetes is managed, as well as key architectural infrastructure advances, which pave the way for a membership service that will deliver more value to DarioHealth's customers and strategic partners. Erez Raphael, Chairman and CEO of DarioHealth, commented, "This is a big milestone for DarioHealth and we are very proud of version 4.0, which comes complete with a slew of new usability and user experience features that enhance user-engagement.

  • DarioHealth to Host First Quarter 2018 Conference Call on May 15, 2018
    PR Newswire6 months ago

    DarioHealth to Host First Quarter 2018 Conference Call on May 15, 2018

    Earnings and Business Update Conference Call Scheduled for 9:00am EDT NEW YORK and CAESAREA, Israel , May 2, 2018 /PRNewswire/ --  DarioHealth Corp. (NASDAQ: DRIO), a leading global digital health company ...

  • DarioHealth Ramps up Commercialization Capabilities
    PR Newswire6 months ago

    DarioHealth Ramps up Commercialization Capabilities

    NEW YORK and CAESAREA, Israel, April 30, 2018 /PRNewswire/ -- DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, announced today it has hired U.S.-based digital health executive JC Muyl as Head of Commercialization North America to head up the Company's business-to-business sales of the Dario Engage platform. This follows the recent appointment of Joao Mendes-Roter as DarioHealth's V.P. of Marketing to lead the Company's robust worldwide direct-to-consumer user engagement and sales.

  • ACCESSWIRE6 months ago

    DarioHealth, New Glucose Monitoring System, Climbing Revenue, and Analysts Target

    NEW YORK, NY / ACCESSWIRE / April 4, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • PR Newswire7 months ago

    DarioHealth Launches Customer Hotline to Pre-Order Its Apple iPhone Lightning-Compatible Glucose Monitor in the U.S.

    NEW YORK and CAESAREA, Israel, March 29, 2018 /PRNewswire/ --  DarioHealth Corp. (DRIO), a leading global digital health company with mobile health and big data solutions, today announced it will offer its past and current subscription holders the option to pre-order its first Lightning®-enabled version of the acclaimed Dario™ Blood Glucose Monitoring System in the U.S. commencing on April 16, 2018. Subscription holders who are interested in ordering the new device will need to place their order through DarioHealth's special hotline for ordering: 1-888-665-7201. DarioHealth expects to ship its first iPhone Lightning-compatible glucose monitor in the coming weeks.

  • Business Wire7 months ago

    SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of DarioHealth Corp.

    Levi & Korsinsky announces it has commenced an investigation of DarioHealth Corp. concerning possible breaches of fiduciary duty. To obtain additional informat